Actemra 400 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHGW9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,763
Award facts
- Contract value 100% obligated
- $17,763.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $17,763.12 by the Defense Logistics Agency on January 28, 2026, for ACTEMRA 400 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting the company's competitive capability in unrestricted federal procurement. Performance will be completed by February 19, 2026, with fulfillment at the contractor's Park Ridge, Illinois location.
This delivery order operates under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, awarded in November 2025 with a $500 million ceiling and completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceuticals and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHGW9?
SPE2DR26FHGW9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FHGW9 worth?
The government has obligated $17,763 on SPE2DR26FHGW9.
Is contract SPE2DR26FHGW9 an order under another contract?
Yes. SPE2DR26FHGW9 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGW9 competed?
The extent of competition for SPE2DR26FHGW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award